hotspot -WSS

hotspot

author：knowledge 2025-09-06 02:05:09 - browse：4521

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Congress: Eradicate hepatitis C and reduce the deficit

WSS

Longer MASH drug regimen improved liver, Akero study finds

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Georgia court denies Trump's request to quash DA's 2020 election probe

Care demand spikes challenge UnitedHealth’s provider arm

Why Talkspace is targeting Medicare, a tricky market

Readout Newsletter: BridgeBio, Akero, and human embryo models

focus

hotspot

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Families look for replacement for GSK asthma drug Flovent

Tori Bowie and the unacceptable rates of Black maternal death

Federal judge rules Oregon’s tough new gun law is constitutional

After affirmative action ruling, medical educators look to 'holistic review'

Longer MASH drug regimen improved liver, Akero study finds

Hollywood unions extend contract negotiations for actors

Harvard's David Sinclair gets blowback over aging

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare: What is it, why does its cyberattack matter?

entertainment

Ancient Greek ideas underpin modern concepts of pregnancy

Pregnant women don't need prenatal multivitamins, study concludes

Lack of health data on LGBTQ+ people has serious consequences

Congress likely to miss an opportunity to fix drug shortages issue

First over

Biden's 'march

focus

explore

hotspot

focus